Who owns BNTC?
Institutional ownership of Benitec Biopharma Inc. from Form 13F, Q2 2026
87 institutional managers reported holding Benitec Biopharma Inc. (BNTC) in Form 13F filings for Q2 2026, with 34,674,062 shares worth $464M. The largest reported holder was Montanova Capital, LLC. Managers that filed both quarters added a net 2,679,192 shares (+9.1%). 11 opened new positions and 10 sold out.
- Funds holding
- 87
- Value held
- $464M
- New / sold out
- 11 / 10
- Net shares, same filers
- +9.1%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of BNTC
Share of 13F holdings is each fund's shares as a share of the 34,674,062 BNTC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Nantahala Capital Management, LLC Added+$20.6M
- Simplify Asset Management Inc. Added+$5.9M
- Millennium Management LLC Added+$3.6M
- BlackRock, Inc. Added+$3.0M
- Geode Capital Management, LLC Added+$1.2M
- Ameriprise Financial Inc Added+$1.1M
- Schonfeld Strategic Advisors LLC Added+$1.1M
- Cantor Fitzgerald, L. P. Added+$624K
- State Street Corp Added+$532K
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Added+$482K
Biggest sellers in Q2 2026
- Longaeva Partners L.P. Trimmed-$1.5M
- Citadel Advisors LLC Trimmed-$1.2M
- Marshall Wace, LLP Sold out-$765K
- Silverarc Capital Management, LLC Trimmed-$507K
- Goldman Sachs Group Inc Trimmed-$501K
- Empery Asset Management, LP Sold out-$324K
- Nuveen, LLC Trimmed-$180K
- Brevan Howard Capital Management LP Sold out-$177K
- Vanguard Fiduciary Trust Co Trimmed-$144K
- Morgan Stanley Trimmed-$130K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $42.3M and sold $6.1M; 37 added and 21 trimmed.
Schedule 13D and 13G filings on BNTC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-12-03RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by Benitec Biopharma Inc.Schedule 13G
Questions about BNTC ownership
- Who owns BNTC stock?
- 87 institutional investment managers reported BNTC positions in their Form 13F filings for Q2 2026, holding 34,674,062 shares worth $464M in total. Montanova Capital, LLC reported the largest position.
- Are funds buying or selling BNTC?
- In Q2 2026, 11 managers opened new BNTC positions, 37 added, 21 trimmed and 10 sold out. Managers that filed in both quarters added a net 2,679,192 shares.
- How current is this BNTC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BNTC by CUSIP. Options are left out. BNTC news and filings · BNTC insider trades · Top funds